Jack Anders - 01 Mar 2024 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role
Chief Financial Officer
Signature
/s/ Jack Anders
Issuer symbol
RVMD
Transactions as of
01 Mar 2024
Transactions value $
$0
Form type
4
Filing time
05 Mar 2024, 16:53:11
Previous filing
20 Dec 2023
Next filing
20 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Award $0 +26.4K +34.37% $0.00 103K 01 Mar 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVMD Stock Option (Right to Buy) Award $0 +92.4K $0.00 92.4K 01 Mar 2024 Common Stock 92.4K $29.80 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 63,726 restricted stock units.
F2 Includes 404 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2023.
F3 One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2024 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.